Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but potentially life-threatening side effect that has only been observed in adenovirus-based vaccines for coronavirus disease 2019 (COVID-19). VITT is an immune-mediated condition that generally presents within five to 10 days post-vaccination with thrombosis, thrombocytopenia, and coagulation abnormalities. A diagnosis of VITT is made clinically and through laboratory testing. Although VITT is an important differential to consider, it is believed that more emphasis should be placed on vaccination due to the safety and efficacy in overcoming COVID-19.
All Keywords
【저자키워드】 COVID 19, vaccine preventable diseases, vaccine-induced thrombotic thrombocytopenia (VITT), heparin induced thrombocytopenia (hit), bilateral thalamic disease, 【초록키워드】 COVID-19, coronavirus disease, Efficacy, Vaccine, vaccination, thrombosis, Diagnosis, immune, Laboratory testing, Coagulation, Immune-mediated, Side effect, thrombotic, Abnormalities, FIVE, clinically, adenovirus-based, potentially life-threatening, 【제목키워드】 COVID-19, thrombocytopenia, coincidence, Bilateral,
【저자키워드】 COVID 19, vaccine preventable diseases, vaccine-induced thrombotic thrombocytopenia (VITT), heparin induced thrombocytopenia (hit), bilateral thalamic disease, 【초록키워드】 COVID-19, coronavirus disease, Efficacy, Vaccine, vaccination, thrombosis, Diagnosis, immune, Laboratory testing, Coagulation, Immune-mediated, Side effect, thrombotic, Abnormalities, FIVE, clinically, adenovirus-based, potentially life-threatening, 【제목키워드】 COVID-19, thrombocytopenia, coincidence, Bilateral,